There are concerns pre-exposure prophylaxis (PrEP) may delay HIV seroconversion, but data are limited. We present a descriptive case note review of HIV testing outcomes from 56 Dean Street, a London sexual health clinic, from 1 January to 31 December 2021. Gender, age, sexual risk, PrEP history (using tenofovir disoproxil and emtricitabine) and HIV testing outcomes (see
PrEP, pre-exposure prophylaxis.
292 screening tests were reactive. Median age was 34.5 years old (IQR 28.5–39.5). 90.4% (n=264) were cis male, of whom 93.2% (n=246) were men having sex with men (MSM); 5.1% (n=15) were cis female with high-risk partners and/or sex workers, and 4.4% (n=13) were transwomen having unprotected anal sex.
Our data show no patients with initial reactive, triple-assay negative tests progressing to a positive HIV test, regardless of PrEP usage. However, it was a retrospective observational review in one clinic with…